In its latest research update, Mirae Asset Sharekhan maintains a BUY recommendation on Tata Consultancy Services (TCS), India’s IT bellwether, despite a challenging quarter marked by subdued revenu

Motilal Oswal has reiterated its BUY rating on Glenmark Pharmaceuticals, setting a compelling price target of Rs 2,430—implying a robust 28% upside from current levels.

Exness has stopped new memberships in India and there isn't any clarification from the company regarding this change.

SBI Life Share price jumped 1.37 percent on Friday and the stock is currently looking bullish on technical charts. We could face minor resistance in range of Rs 1,860 - 1,875.

Kotak Institutional Equities has issued a resounding BUY call on Crompton Greaves Consumer, setting a fair value target of Rs 410 against the current market price of Rs 344.

Ramco Cements, Asahi India Glass and Glenmark Pharmaceuticals shares were among major gainers on Friday.